Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atul is an Indian integrated chemicals company with a meaningful life sciences business spanning pharmaceutical intermediates, active pharmaceutical ingredients, crop protection actives, and related contract manufacturing services. Within healthcare, the company manufactures small-molecule APIs and API intermediates, including phosgene-based and non-phosgene-based products, and operates through its wholly owned subsidiary Atul Bioscience for selected API and intermediate manufacturing. The company is not a drug-development biotech with a clinical pipeline; rather, it is a commercial manufacturer and supplier serving pharmaceutical and broader industrial customers globally. Atul reports its operations across Life Science Chemicals and Performance and Other Chemicals, and serves thousands of customers across numerous industries. Its pharma operations emphasize backward integration, process chemistry, cGMP manufacturing, and export-oriented supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atul.